Logotype for Stora Enso

Stora Enso (STE) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Stora Enso

Q4 2024 earnings summary

15 Dec, 2025

Executive summary

  • Achieved 75% year-on-year growth in adjusted EBIT for 2024, driven by improved sourcing, operational efficiency, and commercial excellence despite challenging markets and rising wood costs.

  • Reduced fixed costs by EUR 110 million and operating working capital by over EUR 700 million in 1.5 years, lowering working capital to sales from 14% to 7%.

  • Announced plans to sell approximately 12% of Swedish forest assets (fair value EUR 6.3 billion) to strengthen the balance sheet and highlight asset value.

  • Board proposes a dividend increase to EUR 0.25 per share, up from EUR 0.20, to be paid in two instalments in 2025.

  • Surpassed 2030 climate target with a 53% reduction in Scope 1 and 2 emissions by year-end 2024.

Financial highlights

  • Full year sales declined by 4% to EUR 9,049 million due to 2023 capacity closures and divestments, but sales for continuing businesses rose 1%.

  • Adjusted EBIT increased by 75% to EUR 598 million, with margin rising to 6.6% from 4% year-over-year.

  • Q4 2024 sales increased 7% year-over-year to EUR 2,322 million; adjusted EBIT up 139% to EUR 121 million (5.2% margin).

  • Net debt increased to EUR 3,707 million due to Oulu investment, but net debt to adjusted EBITDA improved to 3.0x.

  • Cash flow from operations in 2024 was EUR 1,187 million; cash flow after investing activities improved to EUR 88 million.

Outlook and guidance

  • Demand expected to remain subdued and volatile in Q1 2025 due to macroeconomic and geopolitical uncertainty.

  • 2025 adjusted EBIT expected to be adversely impacted by EUR 100 million, mainly in H1, due to Oulu packaging board line ramp-up.

  • Wood prices anticipated to stay high; margin pressures persist in Packaging Materials and Solutions.

  • Price increases achieved in consumer board and announced in containerboard; Biomaterials market near cyclical low with price increases expected to impact Q2.

  • Continued focus on cost reduction and operational excellence to improve competitiveness in 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more